1. Home
  2. SYM vs SWTX Comparison

SYM vs SWTX Comparison

Compare SYM & SWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYM
  • SWTX
  • Stock Information
  • Founded
  • SYM 2005
  • SWTX 2017
  • Country
  • SYM United States
  • SWTX United States
  • Employees
  • SYM N/A
  • SWTX N/A
  • Industry
  • SYM Industrial Machinery/Components
  • SWTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SYM Industrials
  • SWTX Health Care
  • Exchange
  • SYM Nasdaq
  • SWTX Nasdaq
  • Market Cap
  • SYM 3.2B
  • SWTX 3.5B
  • IPO Year
  • SYM N/A
  • SWTX 2019
  • Fundamental
  • Price
  • SYM $34.13
  • SWTX $46.96
  • Analyst Decision
  • SYM Buy
  • SWTX Buy
  • Analyst Count
  • SYM 17
  • SWTX 7
  • Target Price
  • SYM $38.60
  • SWTX $56.86
  • AVG Volume (30 Days)
  • SYM 1.8M
  • SWTX 4.9M
  • Earning Date
  • SYM 07-28-2025
  • SWTX 08-06-2025
  • Dividend Yield
  • SYM N/A
  • SWTX N/A
  • EPS Growth
  • SYM N/A
  • SWTX N/A
  • EPS
  • SYM N/A
  • SWTX N/A
  • Revenue
  • SYM $2,071,248,000.00
  • SWTX $219,670,000.00
  • Revenue This Year
  • SYM $24.43
  • SWTX $74.36
  • Revenue Next Year
  • SYM $31.15
  • SWTX $75.63
  • P/E Ratio
  • SYM N/A
  • SWTX N/A
  • Revenue Growth
  • SYM 42.16
  • SWTX 730.42
  • 52 Week Low
  • SYM $16.32
  • SWTX $28.21
  • 52 Week High
  • SYM $41.76
  • SWTX $62.00
  • Technical
  • Relative Strength Index (RSI)
  • SYM 69.98
  • SWTX 63.41
  • Support Level
  • SYM $30.70
  • SWTX $46.74
  • Resistance Level
  • SYM $38.19
  • SWTX $46.92
  • Average True Range (ATR)
  • SYM 1.98
  • SWTX 0.11
  • MACD
  • SYM 0.43
  • SWTX -0.08
  • Stochastic Oscillator
  • SYM 75.48
  • SWTX 84.81

About SYM Symbotic Inc.

Symbotic Inc is an automation technology company that develops technologies to improve operating efficiencies in modern warehouses. The group develops, commercializes, and deploys end-to-end technology solutions that dramatically improve supply chain operations. Th company also automates the processing of pallets and cases in large warehouses or distribution centers for some of the retail and wholesale companies in the world. The company operates in two geographical regions the United States and Canada. Key revenue is generated from the United States.

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing, and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing prevalent, genetically defined cancers. OGSIVEO, the first commercial product, is a novel, oral, selective gamma-secretase inhibitor. GOMEKLI, the second commercial product, is an oral, small molecule mitogen-activated protein kinase, or MEK, inhibitor.

Share on Social Networks: